Literature DB >> 30774731

Anca Zgura1, Laurentia Galesa1, Elvira Bratila1, Rodica Anghel1.   

Abstract

Year:  2018        PMID： 30774731      PMCID： PMC6362880          DOI： 10.26574/maedica.2018.13.4.317

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN： 1841-9038


× No keyword cloud information.
  8 in total

1.  Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer.

Authors:  Toni Čeprnja; Ivana Mrklić; Melita Perić Balja; Zlatko Marušić; Valerija Blažićević; Giulio Cesare Spagnoli; Antonio Juretić; Vesna Čapkun; Ana Tečić Vuger; Eduard Vrdoljak; Snježana Tomić
Journal:  J Pers Med       Date:  2022-06-08

2.  Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity.

Authors:  John P Murad; Dileshni Tilakawardane; Anthony K Park; Lupita S Lopez; Cari A Young; Jackson Gibson; Yukiko Yamaguchi; Hee Jun Lee; Kelly T Kennewick; Brenna J Gittins; Wen-Chung Chang; Chau P Tran; Catalina Martinez; Anna M Wu; Robert E Reiter; Tanya B Dorff; Stephen J Forman; Saul J Priceman
Journal:  Mol Ther       Date:  2021-02-27       Impact factor: 12.910

Review 3.  Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer.

Authors:  Molly A Nelson; Worapol Ngamcherdtrakul; Shiuh-Wen Luoh; Wassana Yantasee
Journal:  Cancer Metastasis Rev       Date:  2021-05-07       Impact factor: 9.237

4.  Effect of Zinc Supplementation on the Serum Metabolites Profile at the Early Stage of Breast Cancer in Rats.

Authors:  Barbara Bobrowska-Korczak; Paulina Gątarek; Dorota Skrajnowska; Wojciech Bielecki; Rafal Wyrebiak; Tomas Kovalczuk; Robert Wrzesień; Joanna Kałużna-Czaplińska
Journal:  Nutrients       Date:  2020-11-11       Impact factor: 5.717

Review 5.  Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation.

Authors:  Mariana Segovia-Mendoza; Susana Romero-Garcia; Cristina Lemini; Heriberto Prado-Garcia
Journal:  J Immunol Res       Date:  2021-01-07       Impact factor: 4.818

6.  A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study.

Authors:  Sarah N Dudgeon; Si Wen; Matthew G Hanna; Rajarsi Gupta; Mohamed Amgad; Manasi Sheth; Hetal Marble; Richard Huang; Markus D Herrmann; Clifford H Szu; Darick Tong; Bruce Werness; Evan Szu; Denis Larsimont; Anant Madabhushi; Evangelos Hytopoulos; Weijie Chen; Rajendra Singh; Steven N Hart; Ashish Sharma; Joel Saltz; Roberto Salgado; Brandon D Gallas
Journal:  J Pathol Inform       Date:  2021-11-15

7.  PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy.

Authors:  Ahmad Alhesa; Heyam Awad; Sarah Bloukh; Mahmoud Al-Balas; Mohammed El-Sadoni; Duaa Qattan; Bilal Azab; Tareq Saleh
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

8.  Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study.

Authors:  Gislaine Curty; Greta A Beckerle; Luis P Iñiguez; Robert L Furler; Pedro S de Carvalho; Jez L Marston; Stephane Champiat; Jonas J Heymann; Christopher E Ormsby; Gustavo Reyes-Terán; Marcelo A Soares; Douglas F Nixon; Matthew L Bendall; Fabio E Leal; Miguel de Mulder Rougvie
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.